Alzheimer's disease & dementia

Taking proton pump inhibitors not linked to higher dementia risk

Proton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD). As of 2011, up to 1 in 5 older adults reported using a PPI. Although ...

Oncology & Cancer

Esophageal cancer 'cell of origin' identified

Columbia University Medical Center (CUMC) researchers have identified cells in the upper digestive tract that can give rise to Barrett's esophagus, a precursor to esophageal cancer. The discovery of this "cell of origin" ...

Pediatrics

'Sleep positioners' a danger to baby: FDA

(HealthDay)—Infants should be put to sleep on their backs on a firm, empty surface and never placed on a sleep positioner, the U.S. Food and Drug Administration (FDA) says.

Oncology & Cancer

Acid reflux cancer link

Esophageal adenocarcinoma (EA) is an increasingly common cancer that silently affects the esophagus – the muscular tube that moves food into stomach. What causes EA is not well known but gastroesophageal reflux disease ...

Pediatrics

Variation in management for infants with GERD

(HealthDay)—For infants with gastroesophageal reflux disease (GERD), there is considerable variation in diagnostic testing and surgical utilization, according to a study published online July 28 in Pediatrics.

Alzheimer's disease & dementia

New study says PPIs do not cause dementia

Several studies have reported associations between proton-pump inhibitor (PPI) use and dementia. New research published on July 18 in Gastroenterology, the official journal of the American Gastroenterological Association ...

Diseases, Conditions, Syndromes

AGA releases best practice advice on long-term PPI use

When proton pump inhibitors (PPIs) are appropriately prescribed, their benefits are likely to outweigh their risks, according to an American Gastroenterological Association (AGA) Clinical Practice Update1 published in Gastroenterology, ...

page 3 from 13